Agenda Archive

Accelerating drug development: End-to-end strategies for efficient, compliant, and scalable clinical programs

Identifying major bottlenecks across the clinical development lifecycle
Applying regulatory-aligned strategies that shorten timelines without compromising quality
Integrating data, technology, and cross-functional operating models to streamline execution
Optimizing interactions with global regulatory agencies for accelerated pathways
Designing adaptive, patient-centric, and data-efficient clinical trials

Building an operating model that aligns sponsors, CROs, and clinical sites around shared timelines and delivery expectations
Operational strategies for condensing early-phase development timelines while maintaining trial quality and oversight
Cellectar Biosciences case study: Lessons from a COO on partnering with CROs and clinical sites to rapidly execute studies and meet key clinical milestones
Managing operational complexity when multiple partners support a single oncology program

How to choose fit-for-purpose endpoints in modern trial design
When digital endpoints add value, and why many trials still avoid them
Differences in decision-making and risk tolerance: large pharma vs. biotech
Managing complexity through outsourcing: letting vendors do the heavy lifting while you focus on the data
Keeping scientific and data ownership while external partners handle execution
Practical lessons from real-world trial designs: what worked and what didn’t